Search details
1.
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Blood
; 141(18): 2194-2205, 2023 05 04.
Article
in English
| MEDLINE | ID: mdl-36796016
2.
IL-8 correlates withĀ nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism.
Mol Carcinog
; 62(9): 1428-1443, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37401875
3.
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.
J Clin Oncol
; 42(4): 467-480, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38079587
4.
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma.
bioRxiv
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38328071
5.
Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data.
Commun Biol
; 7(1): 392, 2024 Mar 30.
Article
in English
| MEDLINE | ID: mdl-38555407
6.
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.
Cancer Res
; 84(1): 101-117, 2024 01 02.
Article
in English
| MEDLINE | ID: mdl-37801604
7.
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients.
Cancer Cell
; 42(3): 444-463.e10, 2024 Mar 11.
Article
in English
| MEDLINE | ID: mdl-38428410
8.
B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma.
JTO Clin Res Rep
; 4(7): 100527, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37521368
9.
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis.
Front Oncol
; 13: 1274163, 2023.
Article
in English
| MEDLINE | ID: mdl-38318324
10.
B cell-dependent subtypes and treatment-based immune correlates to survival in stage 3 and 4 lung adenocarcinomas.
FASEB Bioadv
; 5(4): 156-170, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-37020749
11.
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
Blood Cancer Discov
; 3(5): 428-443, 2022 09 06.
Article
in English
| MEDLINE | ID: mdl-35687817
12.
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 28(5): 915-927, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-34911681
13.
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes.
Cancer Cell
; 40(8): 879-894.e16, 2022 08 08.
Article
in English
| MEDLINE | ID: mdl-35944503
14.
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.
Cancer Cell
; 39(6): 845-865.e7, 2021 06 14.
Article
in English
| MEDLINE | ID: mdl-34019806
15.
Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma.
Front Oncol
; 11: 677051, 2021.
Article
in English
| MEDLINE | ID: mdl-34336664
16.
Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma.
J Exp Med
; 218(3)2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33237303
17.
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures.
Cancer Discov
; 11(6): 1468-1489, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33541860
18.
Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas.
Cancer Res
; 81(20): 5202-5216, 2021 10 15.
Article
in English
| MEDLINE | ID: mdl-34479963
19.
Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.
Clin Cancer Res
; 27(12): 3478-3490, 2021 06 15.
Article
in English
| MEDLINE | ID: mdl-33771855
20.
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations.
J Immunother Cancer
; 9(7)2021 07.
Article
in English
| MEDLINE | ID: mdl-34244308